Unlikely to cause harm — often a labeling or packaging issue.
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
| Brand name | VARENICLINE TARTRATE |
| Generic name | VARENICLINE TARTRATE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 43598-908-56 |
| Full product label | Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Distributed Nationwide |
| Quantity | 4800 54-count bottles |
| Recall initiated | 2025-11-11 |
| Report date | 2025-12-17 |
| Recall completed | — |
| Recall number | D-0219-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗